MSBs product mentioned in Japan. BUT Gen 1 harvesting tech
GvHD fine for now - not a big target, BUT what happens when Billions cells are required for the 650 trials for MSCs pass P3 or P2 in Japan??
This is the biggest elephant in the commercialization of stem cell therapies.
Why the big drop?, page-20
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.48 |
Change
0.125(9.26%) |
Mkt cap ! $1.644B | |||
| Open | High | Low | Value | Volume |
| $1.37 | $1.48 | $1.37 | $12.27M | 8.612M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 6645 | $1.48 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.48 | 408086 | 17 |
View Market Depth
| Last trade - 11.53am 04/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |